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Abstract 
The widespread use of antibiotics in food animal production systems has 
resulted in the emergence of antibiotic resistant zoonotic bacteria that can be 
transmitted to humans through the food chain. Infection with antibiotic 
resistant bacteria negatively impacts on public health, due to an increased 
incidence of treatment failure and severity of disease. Development of 
resistant bacteria in food animals can result from chromosomal mutations but 
is more commonly associated with the horizontal transfer of resistance 
determinants borne on mobile genetic elements.  Food may represent a 
dynamic environment for the continuing transfer of antibiotic resistance 
determinants between bacteria. Current food preservation systems that use a 
combination of environmental stresses to reduce growth of bacteria, may 
serve to escalate development and dissemination of antibiotic resistance 
among food related pathogens. The increasing reliance on biocides for 
pathogen control in food production and processing heightens the risk of 
selection of biocide-resistant strains. Of particular concern is the potential for 
sublethal exposure to biocides to select for bacteria with enhanced multi-drug 
efflux pump activity capable of providing both resistance to biocides and 
cross-resistance to multiple antibiotics. Although present evidence suggests 
that biocide resistance is associated with a fitness physiological costs, the 
possibility of the development of adaptive mutations conferring increased 
fitness cannot be out-ruled.  Strategies aimed at inhibiting efflux pumps and 
eliminating plasmids could help to restore therapeutic efficacy to antibiotics 
and reduce the spread of antibiotic resistant food borne pathogens through 
the food chain. 
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1. Introduction 
Over the last two decades there has been an increase in the number of 
antibiotic resistant bacteria isolated from humans and animals.  The overuse 
and misuse of antibiotics in both human and veterinary medicine has 
contributed to this global pandemic of antibiotic resistant bacteria [1]. In 
contrast to human medicine, antibiotics are used therapeutically, 
prophylactically and sub-therapeutically as growth promoters in food animals 
[2]. This has led to the development of resistance to antibiotics in foodborne 
pathogens which can ultimately be transmitted to humans via the food chain 
[3,4]. Although most cases of foodborne disease result in self-limiting 
diarrhoea, antibiotic therapy is warranted in cases of persistent enteritis, 
bacteraemia and in immunocomprised individuals.  Infection with antibiotic 
resistant bacteria can complicate initial treatment and result in prolonged 
duration of illness, an enhanced risk of mortality or invasive illness and 
increased healthcare costs. The Centers for Disease Control and Prevention 
estimate that foodborne diseases are responsible for about 76 million 
illnesses, resulting in 325,000 hospitalisations and 5,000 deaths in the United 
States each year [5]. 
Antibiotic resistance typically occurs as a result of target gene mutation, drug 
inactivation and decreased accumulation resulting from decreased 
permeability and /or increased efflux [6]. The horizontal transfer of resistance 
determinants on mobile genetic elements such as plasmids, transposons and 
integrons, promotes the rapid spread of antimicrobial resistance genes 
between different species and genera of bacteria and the development of a 
multi-drug resistance phenotype. More recently, considerable attention has 
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focussed on the role of multi-drug efflux pumps in mediating multi-resistance 
[7].  
In response to the concern about the growing impact of antibiotic resistance in 
clinical practice, European Union (EU) regulations have banned the use of 
antibiotic growth promoters in animal feed [8].  Consumer demands for safe 
food has resulted in an increase in biosecurity measures in the food 
production industry, including the use of biocides to control and reduce 
microbial communities associated with food spoilage and disease [9]. 
Additionally, the increased public awareness of hygiene has resulted in a 
deluge of consumer healthcare and cleaning products touting antimicrobial 
uses [10]. Increased exposure to biocides has contributed to the emergence 
of pathogens showing decreased suceptibility to them. Resistance to biocides 
may be due to target gene mutations [11, 12], however, it is more commonly 
associated with increased efflux pump activity [13,14,15]. As antibiotics are 
substrates for these pumps, also this also raises the concern that biocides 
can select for multi-drug resistance in clinically important  bacteria in the 
absence of antibiotic selective pressure [16].   
 
This review examines the contribution of stresses encountered in the food 
processing environment to the emergence and spread of antibiotic resistance. 
Consideration is given to the use of biocides by the food industry and the 
emergence of resistance to these agents. Mechanisms associated with 
biocide resistance and the potential for biocides to select for antibiotic 
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resistant bacterial are explored.  Finally, the fitness physiological cost of 
biocide resistance is examinedexplored.  
 
2. Horizontal transfer of antibiotic resistance 
Although chromosomal mutations can be responsible for the development of 
antibiotic resistance [17], mutation occurs at a relatively low frequency of one 
per 1 billion cell divisions [18]. Consequently, transferable resistance poses a 
greater threat as it can achieve much larger dimensions owing to widespread 
rapid dissemination among bacteria of different taxonomic and ecological 
groups [18]. Genetic exchange can occur by conjugation (plasmid-mediated), 
transduction (bacteriophage-mediated) or transformation (which may involve 
plasmids and naked DNA). Conjugation is the most frequently recognised 
mechanism for horizontal gene transfer. Plasmids may contain particular 
genetic structures including composite and/or complex transposons, known as 
“jumping genes” along with the more recently described integron structures 
(Figure 1), which can increase the rate of dissemination of resistance genes 
between bacteria.  Integrons can capture antibiotic resistance encoding genes 
via site-specific recombination [19, 20]. These integrons possess a conserved 
structure on the proximal end (known as the 5’-CS) containing an integrase 
gene (intI), a recombination site (attl) and a promoter (Pant), along with a 
conserved distal region (3’-CS) containing a qacE1 [conferring resistance 
to quaternary ammonium compound(s) (QAC’s)] and a sul1 determinant 
(conferring resistance to sulphonamide).  These CS regions flank a variable 
central locus, into which gene cassettes are recombined, composed of one or 
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more open reading frames (ORF) encoding antibiotic resistance gene(s) [21].  
More then 60 different gene cassettes have been identified, with some 
integrons possessing multiple gene cassettes arranged in a classical ‘head-to-
tail’ orientation [22].  As these resistance determinants are under the control 
of a single strong upstream promoter (located towards the 3’ end of intI), all 
recombined gene cassettes are co-expressed.  Therefore, selective pressure 
imposed by the use of a particular antibiotic, can co-select for another 
resistance determinant located within an adjacent gene cassette [23].  
Additionally, exposing integron-containing bacteria to sub-inhibitory levels of 
QACs may co-select for antibiotic resistance [24]. 
 
2.1 Antibiotic resistance transfer in food and the effect of food 
preservation stresses 
Gene transfer has been shown to occur in a variety of complex media 
including the gut of various animals [25], the human colon [26], cultured 
human cells [27], bovine rumen fluid [28], sewage [29], surface water [30] and 
calf faeces [31]. Several studies to-date have successfully demonstrated 
laboratory-based gene transfer by conjugation with food-borne bacterial 
strains in broth (liquid mating) [32, 33, 34] or by filter (solid surface) mating 
[35, 36]. However, there is limited data describing gene transfer in the in situ 
food matrix [37].   
Walsh et al. (2008) reported the transfer of an ampicillin resistance marker via 
a R-plasmid from S. Typhimurium DT104 to a susceptible recipient E. coli K12 
in broth, milk and ground meat, at 25 and 37oC within 24 h.  A higher rate of 
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transfer (10-2 cfu/g transconjugants per recipient) was reported in ground 
meat at 48 h [38].  Similarly, Van der Auwera et al. (2007) reported plasmid 
transfer (at 10-1 cfu ml/g  transconjugants per recipient) for Bacillus 
thuringiensis in broth, milk and milk pudding [39].  Cocconelli et al. (2003), 
reported the transfer of a vancomycin resistance gene via a conjugative R-
plasmid in enterococcal strains during cheese and sausage fermentation [37].  
These authors reported a 2-3 log (cfu/g) increase in the transfer rate of 
plasmids in meat, and suggested that factors including plasma in the meat 
matrix could play an important role in increasing the rate of plasmid transfer 
[40].   
Recent evidence suggests that plasmid transfer may also be more rapid 
between bacteria in minimally processed foods, held under sub-lethal food 
preservation stresses such as high/low temperature, osmotic and pH stress. 
Using experimental broth/filter mating conditions, McMahon et al., (2007) 
reported significantly increased rates of antibiotic resistance plasmid transfer 
between E. coli strains and E. coli and S. Typhimurium strains held under the 
typical environmental food preservation stresses used by the food industry 
[41].  However, it was not determined whether this was due to increased 
donor plasmid transfer or more efficient plasmid capture by the recipient. On a 
positive note, biocides have been show to reduce the rates of plasmid transfer 
(by both conjugation and transduction) [68] 
 
3. Biocides and their use in food production  
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Biocides refer to a broad category of agents including sanitizers, disinfectants 
and food preservatives [24] (see Figure 2-which provides a general summary 
of this classification).  For the purposes of this review we will confine our 
discussion to the first two listed categories. Biocides which include 
disinfectants and sanitizers can be further differentiated based on the 
organism(s) they target and directions for use [42].  A disinfectant must 
completely eliminate all the organisms against which it is directed, whilst a 
sanitizer need not eliminate all of the organisms that it is targeted against. The 
efficacy of biocides and the types of organisms that they inhibit vary 
considerably, and is dependent on the compositional concentration and 
synergism among the components [43].  Compared to antibiotics, the mode of 
action of biocides is relatively non-specific.  They damage cytoplasmic 
membranes and can react unspecifically with functional groups of proteins or 
nucleic acids [44].  
Biocides are used as part of the biosecurity measures in livestock production 
to prevent outbreaks and spread of disease and to decontaminate animal 
housings. In the food processing environment they are used to prevent 
product contamination with pathogens.  Commonly used biocides for  
environmental and surface cleaning include, quaternary ammonium 
compounds (QAC’s), oxidising compounds, acid anionics, hypochlorite and 
chlorine dioxide.  Triclosan and chlorhexidine are used extensively in 
handcare products [45]. Unusually unlike the approval process for antibiotics, 
a risk assessment of the development of biocide resistance is not considered 
during the approval of biocides for food industry use.   
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3.1. Mechanisms associated with decreased susceptibility to biocides 
It was considered highly unlikely that resistance to biocides would ever occur, 
as most biocides are complexes of antimicrobial agents that act in unison to 
inactivate multiple cellular targets [46,47].  However, reduced susceptibility to 
biocides was first reported a century ago [48] and our current high 
dependance on biocides, has resulted in some reports of reduced bacterial 
susceptibility [49-53]. While reduced susceptibility to biocides does not 
necessarily correlate with product failure, the implication of ineffective 
pathogen control may be damaging to the food industry. Factors reducing the 
effectiveness of biocides include the presence of organic material and biofilm 
growth.  Inadequate disinfection procedures in livestock production facilities 
and food processing plants may contribute to the selection of biocide resistant 
isolates as a result of exposure to sublethal biocide concentrations. 
Staphylococci showing decreased susceptibility to QACs have been isolated 
from food processing plants (54, 55).  Langsrud and Sundheim (1997) 
reported that more than 30% of Pseudomonas spp. isolated from poultry 
carcasses could grow in the presence of benzalklonium chloride at 
concentrations used in the poultry plant (56). Resistance to QACs has been 
demonstrated in Listeria spp. isolated from poultry products, red meat  and 
cheese [57].  In contrast a recent report showed that biocide resistance was 
not a contributing factor to the persistence of strains of L. monocytogenes and 
E. coli in the products and environment of five chilled food production facilities 
(58). Although little is known about the effects of low concentrations of 
biocides  on bacterial biofilms, of potential significant to the food industry is 
For mat t ed:  Font :  I t al i c
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the results of in-vitro studies showing that incomplete elimination of a biofilm 
might lead to increased resistance after biofilm growth possibly due to the 
selection of highly resistant clones. [59, 60] 
Mechanisms of aquired antibiotic resistance have been widely studied and 
clearly elucidated [19,20]. Comparatively, mechanisms of acquired biocide 
resistance have been poorly evaluated.  Biocide resistance can result from 
mutation or from acquisition of resistance determinants on plasmids [54]. 
Resistance resulting from biocide inactivation is rare but has been 
documentated for organomercurials [61,62]. Resistance can also result from 
changes in cell permeability but is more often associated with enhanced 
biocide efflux [61].  
A number of efflux transporters capable of effluxing a single substrate, or a 
wide variety of structurally unrelated agents including antibiotics and biocides, 
have been identified in bacteria.  The contribution of these efflux pumps to 
antibiotic resistance is well documented and has been the subject of 
numerous reviews [63-66].  Bacterial efflux systems are classified into five 
families: the major facilitator (MF) superfamily, the ATP (adenosine 
triphosphate)-binding cassette (ABC), the resistance nodulation-division 
(RND) family, the small multi-drug resistance (SMR) family (a member of the 
much larger drug/metabolite transporter (DMT) superfamily), and the multi-
drug and toxic compound extrusion (MATE) family [67].  Of these, MF 
transporters are the most prevalent in Gram-positive bacteria [Figure 3 (a)] 
and the RND transporters are the most common in Gram-negative bacteria 
[(see Figure 3 (b)]). RND efflux pumps are organised as tripartite structures 
consisting of an inner membrane pump, an outer membrane protein and a 
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periplasmic linker protein. Multi-drug efflux pumps such as RND pumps, are 
generally chromosomally encoded, and their over-expression can result from 
mutations in local or global regulators.  This contrasts with drug-specific efflux 
pumps, which are more usually encoded by mobile genetic elements [67] and 
are single component structures [68].   
Here we will review the mechanisms of resistance associated with some of 
the commonly used biocides, namely; triclosan, quaternary ammonium 
compounds (QAC's) and chlorhexidine [47,66] (see Figure 4- for chemical 
structure). 
Triclosan 
Triclosan works specifically on enoyl-acyl reductase, an enzyme which is 
essential for fatty acid synthesis. Modification, repression or deletion of the 
specific cellular target fabI (encoding enoyl-acyl reductase) results in reduced 
bacterial susceptibility to triclosan [11,12,68].  Triclosan has been reported to 
target the FabI enzyme of a number of bacteria including spoilage organisms 
such as P. aeruginosa and food pathogens such as E. coli, Salmonella and 
Campylobacter. Characterisation of triclosan resistant mutants, revealed a 
single-amino-acid change in fabI in the codon for glycine 93 in E. coli and 
glycine 95 in P.aeruginosa (68).  Additionally, many of the RND family pumps 
associated with resistance to clinically important antibiotics are able to 
accomodate triclosan.  These include the AcrAB-TolC pump of E. coli [15] and 
Salmonella [69], the CmeABC and CmeDEF of C. jejuni [70],  and several of 
the Mex pumps in P. aeruginosa [71].  
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Quaternary ammonium compounds  
Quaternary ammonium compounds (QAC e.g. benzalkonium chloride) act by 
physical disruption and partial solubilisation of the cell and membrane.  A 
variety of plasmid and chromosomally encoded efflux determinants of QAC 
resistance have been described in both Gram-negative and positive bacteria 
[68]. Transporters capable of accomodating QACs in Gram-negative bacteria 
are generally chromosomally encoded and include a number of  MATE 
(PmpM in P.aeruginosa), RND  (AcrAB-TolC, AcrEF-TolC  and YhiUV-TolC 
pumps of E. coli), [64] and SMR family (EmrE in E. coli) [72] multi-drug 
transporters. The SMR transporters, QacE and QacE1, QacF and QacG 
found in Gram-negative bacteria are plasmid-encoded [73,64].  Interestingly, 
as stated earlier the qacE1 is contained on the conserved distal region (3’-
CS) of a class 1 integron structure (Figure 1c).  The chromosomal efflux 
determinants of QAC resistance in Gram-positive bacteria include the MF 
family NorA multi-drug transporter (usually associated with fluoroquinolone 
resistance), the MF family MdeA and the MATE family MepA in S. aureus [74, 
75, 76). In contrast to Gram-negative bacteria, the main mechanism of QAC 
resistance in Gram-positive bacteria is plasmid-borne efflux, due to the SMR 
family transporters QacC/D and QacE1, QacG, QacH and QacJ  and the MF 
family QacA/B transporter [64]. 
Chlorhexidine 
Bactericidal concentrations of chlorhexidine result in a denaturation of 
cytoplasmic proteins and coagulation of the cell contents.  The specific 
For mat t ed:  Font :  Bol d
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mechanism(s) associated with chlorhexidine resistance still remain to be 
elucidated. However, chlorhexidine resistance has been associated with 
cepA, encoding a putative efflux mechanism in K. pneumoniae [77].  Indirect 
evidence for the role of RND family exporters in chlorhexidine resistance has 
been provided. Benzalkonium chloride and triclosan adapted E. coli displayed 
a multi-drug-resistance phenotype including reduced susceptibility to 
chlorhexidine, consistent with increased expression of an RND multi-drug 
transporter [78].   Chlorhexidine has been shown to induce expression of the 
MexCD-OprJ efflux pump in P. aeruginosa, although a role in chlorhexidine 
resistance was not examined [79]. QacA/B in Gram-positive bacteria reduces 
susceptibility to chlorhexidine [64, 79] 
3.2 Links between biocide and antibiotic resistance 
The link between biocide and antibiotic resistance has mainly been studied in 
the laboratory by selecting bacteria with decreased susceptibility to biocides.   
Numerous studies have clearly demonstrated that selection for biocide 
resistance can result in cross-resistance to antibiotics [80-83].  Furthermore, 
several studies have unequivocally demonstrated that selection for multiple 
antibiotic resistance results from increased expression of multi-drug 
transporters capable of accommodating both biocides and antibiotics [9, 15, 
16, 71, 84, 85, 86].  Triclosan has been shown to select for multiple antibiotic 
resistant P. aeruginosa overpressing the MexCD and MexJK efflux systems 
[71, 87], E. coli [15] and Salmonella [9] overexpressing the AcrAB  multi-drug 
efflux pump and more recently Stenthrophomonas. maltophilia overproducing 
the SmeDEF multi-drug efflux pump [88].  Similarily, QAC can select for 
resistant S. aureus isolates showing cross resistance to fluoroquinolones as a 
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result of increased norA expression [89] and a modest cross resistance to 
several antibiotics as a result of overproduction of MdeA [90]. Exposure to 
sub-lethal levels of a QAC disinfectant containing formaldehyde and 
glutaraldehyde has also been shown to select for multiple antibiotic resistance 
in Salmonella associated with overexpression of AcrAB-tolC [9].  
In vivo, the relationship between biocide use and antibiotic resistance is less 
clear, with no conclusive evidence being provided to date to suggest that the 
observed laboratory phenomena have relevance to the real world [63].  A 
recent study reported a lack of correlation between biocide and antibiotic 
resistance in bacteria isolated from homes that used or did not use biocide 
containing products [91]. Similarly, no correlation was evident between 
biocide and antibiotic resistance in a large number of clinical S. aureus and P. 
aeruginosa isolates studied over a 10 year period [92]. In contrast, a 
comparison of clinical and industrial isolates of P. aeruginosa revealed that 
antibiotic/biocide correlations occured with clinical strains only. Studies on 
Gram-negative organisms found in urinary tract infections revealed  significant 
correlations between biocide resistance and multiple antibiotic resistance [93, 
94]  
 
4. Physiological impacts associated with biocide resistance-is there a 
link? 
Studies have shown that when cells encounter a stress, such as the selective 
pressure imposed by an antibiotic or a biocide, the cell alters its physiological 
status enabling it to survive  [80,95].  The precise detail of how different 
For mat t ed:  Font :  I t al i c
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bacterial cells respond and what occurs at the functional level is currently 
incomplete.  Nevertheless, it is possible to generalize about some of the 
molecular responses (as shown in Figure 5).  In the absence of externally 
applied stresses, a bacterial cell would be expected to maintain its normal 
physiological state (Figure 5 [a]), assuming that appropriate nutrients and 
other factors were plentiful.  Imposing a particular stress (Figure 5 [b] -
antibiotic or biocide) causes the cell to transduce this signal into the 
cellcytolasm.  At a molecular level, one or several genes will respond [24,96].  
In some cases expression is switched on (eg: as typified by the chaperones 
groEL and others) [97 98], whilst in others gene expression is switched off.  
These effects are probably transient and normal status is reinstated once the 
stress has disappeared.  In contrast, when a different stress is imposed 
(Figure 5 [c] –acid) the cell reacts accordingly and yetanother set of genes 
display differential regulation patterns.  Some of these genes may be common 
and react similarly as in the former case.  However, at a functional level, the 
resulting phenotype may be very different. 
 
Exposure of bacteria originating in animals treated with antibiotics may 
provide for a pre-adaptation in some important zoonotic bacteria (including 
Salmonella and Campylobacter).  The capacity of food-borne bacteria to 
survive stresses encountered along the food chain is an important factor 
aiding their transmission from animals to humans.  Subsequent stressing of 
these organisms further along the food chain may serve to increase their 
ability to resist any new stresses imposed (combinations of effects outlined in 
Figures 5[b] and [c]). 
  16 
   
The nature of the relationship between antibiotic/biocide resistance and 
associated physiological impacts, is only now beginning to be explored.  Early 
descriptions are at best conflicting.  Both antibiotics and biocides can induce 
the expression of efflux pumps, but this is likely to be just one of many 
responses at the functional level and no clear description has emerged.  
Several studies have shown that low level biocide resistance exhibited by 
cells results in slower growth rates compared to their isogenic parents [99-
100].  Similarly, when S. Typhimurium was selected after exposure to 
aldehyde, oxidizing and tar-acid based disinfectants, these mutants displayed 
reduced growth rates, reduced colony size and were less invasive when co-
cultured with Caco-2 cells, compared to their isogenic non-selected parent 
strains [102, 103].  Karatzas, et al., (2007) also reported that when S. 
Typhimurium was selected on a number of commercially applied disinfectants 
(including triclosan), mutants recovered had reduced growth rates reduced 
invasiveness, as determined using Caco-2 cells [9].   These observations 
conflicted with those reported by Webber et al. 2008, showing increased 
fitness in Salmonella following selection in triclosan [104]. 
In E. coli triclosan has been reported to down-regulate some virulence 
promoters of outer membrane protein X and p-fimbriae, however these effects 
appear to be transient [105].  Starvation and exposure of E. coli O157:H7 to 
sodium hypochlorate (such stresses are likely to be encountered by bacteria 
in the food production environment) influenced the virulence potential of this 
organism.  Virulence factors including stx (encoding verocytoxins) and 
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attachment components were up-regulated [106].  These contributed to the 
survival of this human pathogen. 
 
Conclusions 
The advent of multi-drug resistant (MDR) pathogens has created a public 
health issue.  Recent reports highlight the importance of food as an avenue 
for the dissemination of antibiotic resistant genes to humans, thereby reducing 
the efficacy of our current arsenal of drugs.  To effectively combat this 
problem, a comprehensive understanding of the mechanisms involved are 
essential.  The isolation of antibiotic resistant pathogens from retail food 
products, underpins the fact that a potential reservoir of antibiotic resistant 
bacteria may exist within the food -chain.  It is speculative whether or not, 
depending on the genotypes of these organisms, the efficacy of biocides may 
be also be compromised. 
 
It is unclear, at present whether a link between antibiotic and biocide 
resistance exists  in-vivo.  Although laboratory data appears to support such a 
link, there is a lack of convincing evidence from natural sources, despite the 
involvement of some common mechanisms including efflux pumps.  However, 
all studies agree the prudent use of antimicrobials (antibiotics and biocides)  is 
important. 
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  In the absence of any new antibiotics, the importance of plasmid-mediated 
resistance transfer and efflux pumps, in the development and maintanance of 
antibiotic resistance cannot be underestimated.  Effective strategies aimed at 
plasmid curing and inhibition of efflux pump activity would be legitimate 
targets to pursue in the expectation that novel inhibitors could be developed.  
Neither compound type has been licensed for use in the treatment of bacterial 
infections in human and veterinary medicine.  In gaining a better 
understanding of these mechanisms, it may be possible in the future to 
develop a rationally-based inhibitor(s), based on the kowledge of structurally 
vulnerable targets. 
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Figure legends 
Figure 1:  Structure of composite (a), complex (b) transosons and integrons 
associated with antibiotic resistance in bacteria. 
Figure 2:  A schematic representation of the current categorisation of 
antimicrobials 
Figure 3: Schematic diagram of the main efflux determinants of biocide 
resistance in (a) Gram-positive and (b) Gram-negative bacteria                     
Figure 4:  Chemical structure of benzalkonium chloride (QAC’s), 
chlorhexidine and triclosan 
Figure 5:  A general schematic illustrating the responses at a molecular level 
in a cell under normal (a), antibiotc/biocide stress (b) and acid stress (c) 
conditions. 
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